JFJoseph T. Flynn

Joseph T. Flynn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Joseph T. Flynn has a total of 565 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Triumphs and challenges

    by Joseph T. Flynn, Giovanni Montini

  • Natural History of C3 Glomerulopathy and Immune Complex-Associated Membranoproliferative Glomerulonephritis in Children

    by Bradley P. Dixon, Benjamin L. Laskin, Amy J. Goodwin Davies, Hanieh Razzaghi, Mitchell G. Maltenfort, Sherin Meloni, Melissa E. Thomas, Joseph T. Flynn, Donna J. Claes, Mark Mitsnefes, et al.

    Background: C3 glomerulopathy (C3G) and immune complex-associated membranoproliferative glomerulonephritis (IC-MPGN) are rare complement-mediated kidney diseases with a high risk of progression to kidney failure. Little is known about the natural history of these diseases in children, limiting our understanding of risk factors for progressive kidney disease. Methods: Using a computable phenotype algorithm, a pediatric cohort with C3G or IC-MPGN was identified at seven institutions in PEDSnet, a national network of pediatric health systems which aggregate electronic health record data and collaborate on pragmatic research studies. Discrete data elements were captured from electronic health records and additional clinical and histopathologic data were extracted by standardized chart review by pediatric nephrologists. Biopsy diagnosis was classified as C3G or IC-MPGN by applying an algorithm based on immunofluorescence and electron microscopy and supplemented with manual chart review. Kaplan-Meier survival curves were utilized to compare the risk of reaching a composite kidney outcome of 50% reduction in estimated glomerular filtration rate (eGFR), initiation of maintenance dialysis, or kidney transplantation. Results: Of 204 patients with MPGN identified by the computable phenotype algorithm and chart review, 159 could be further classified as C3G or IC-MPGN based on available biopsy data. There were no significant differences in baseline serum albumin, C3 level, urine protein/creatinine ratio, or eGFR between C3G or IC-MPGN. Patients with C3G and IC-MPGN had similar rates of progression to the composite kidney outcome, and a low serum C3 level at baseline was associated with this composite outcome. Conclusion: Using large-scale, real-world multi-institutional data, we investigated the natural history of a large contemporary cohort of children with MPGN. As patients classified as having C3G compared to IC-MPGN had similar baseline clinical characteristics and rates of progressive disease despite untargeted treatment approaches, the availability of newer complement-targeted agents hold the promise of benefit to this population.

  • Open Access

    Global trends and geographic variations of hypertension in childhood and adolescence 1990–2021: a systematic analysis of the Global Burden of Disease Study 2021

    by Yu Hyeon Chu, Jueon Kim, Sarah Soyeon Oh, Jong Hoon Han, Min Seo Kim, Dong Keon Yon, Jae Il Shin, Joseph T Flynn

    Chu YH, et al. Clin Hypertens. 2026 ;32(1):e30. https://doi.org/10.5646/ch.2026.32.e30

  • Open Access

    Pre- and postnatal exposure to PM2.5 and NO2 and blood pressure in children: Results from the ECHO Cohort

    by Yu Ni, Andrew Law, Xingyu Gao, Adam A. Szpiro, Christine T. Loftus, Miranda Jones, Logan C. Dearborn, Marnie F. Hazlehurst, Allison R. Sherris, Sindana Ilango, et al.


  • Shiny and Mobile Apps for Estimating Blood Pressure Percentiles in Children

    by Laura Montelisciani, Bernard A. Rosner, Joseph T. Flynn, Laura Antolini, Marco Giussani, Giacomo Pucci, Simonetta Genovesi

    BACKGROUND: The American Academy of Pediatrics, the European Society of Hypertension, and the European Society of Cardiology propose distinct hypertension classification criteria for children and adolescents based on 2 percentile derivations and different fixed blood pressure thresholds at different ages, leading to potential confusion in clinical and research settings. METHODS: We developed 2 Shiny apps and 1 mobile app that allow simultaneous calculation of blood pressure percentiles using both methods and classify hypertension according to each guideline. The first Shiny app was designed for research purposes, offering an efficient tool for handling large pediatric data sets. The second Shiny app and the mobile app are designed for clinical use, presenting the same relevant outcomes for individual patients in a user-friendly interface. The research-focused app was tested on 3 data sets varying in age, blood pressure, and weight distributions. RESULTS: When comparing the 3 hypertension classifications across the samples, the American Academy of Pediatrics and European Society of Cardiology criteria consistently identified more individuals as hypertensive than the European Society of Hypertension across all age and weight groups, resulting in discordance rates from 2.3% to 21.1%. In contrast, the American Academy of Pediatrics and the European Society of Cardiology showed high agreement, with minimal or absent discordance ranging from 0.0% to 4.4%. An exception was seen in ages of 13 to 16 years, where differing criteria led to greater and unpredictable discordance. CONCLUSIONS: These apps offer researchers and clinicians powerful tools to calculate blood pressure percentiles and hypertension classifications based on different guidelines. This marks an important first step toward identifying which classification best predicts clinical outcomes.

  • Youth Blood Pressure and Target Organ Injury Markers: The SHIP AHOY Study

    by Gilad Hamdani, Elaine M. Urbina, Stephen R. Daniels, Bonita E. Falkner, Michael A. Ferguson, Joseph T. Flynn, Coral D. Hanevold, Julie R. Ingelfinger, Philip R. Khoury, Marc B. Lande, et al.

    BACKGROUND: Hypertension in adolescence is associated with subclinical target organ injury. We aimed to determine whether different blood pressure thresholds were associated with an increasing number of target organ injury markers in healthy adolescents. METHODS: A total of 244 participants (mean age 15.5±1.8 years, 60.1% male adolescents) were studied. Participants were divided based on systolic clinic and systolic awake ambulatory blood pressure into low- (90th percentile) groups. The ambulatory blood pressure phenotype was classified as normotensive, white-coat, masked, or sustained hypertension. Target organ injury assessments included left ventricular mass, systolic and diastolic function, and vascular stiffness. A multivariable general linear model was constructed to evaluate the association of different participant characteristics with higher numbers of target organ injury markers. RESULTS: A total of 31.2% of participants had 1, 11.9% 2, 3.7% 3, and 0.8% 4 target organ injury markers. The number of target organ injury markers increased according to the risk groups: the percentage of participants with >1 marker in the low-, mid-, and high-risk groups was 6.7%, 19.1%, and 21.8% ( P =0.02) and 9.6%, 15.8%, and 32.2% ( P 1 target organ injury marker than normotensives (8%, P <0.001). The results were unchanged in multivariate analysis. CONCLUSIONS: High clinic and ambulatory blood pressure values, as well as ambulatory blood pressure phenotypes (white-coat, masked, and sustained hypertension), were independently associated with an increasing number of subclinical cardiovascular injury markers in adolescents.


  • Open Access

    How many times should blood pressure be measured?

    by Joseph T. Flynn, Susan M. Halbach, Coral D. Hanevold, Yousuke Miyashita


  • Ambulatory Blood Pressure Phenotype and Cardiovascular Risk in Youth: The SHIP-AHOY Study

    by Joseph T. Flynn, Philip R. Khoury, Michael A. Ferguson, Coral D. Hanevold, Marc B. Lande, Kevin E. Meyers, Joshua A. Samuels, Elaine M. Urbina


  • Systolic Blood Pressure, Cardiovascular Health, and Neurocognition in Adolescents

    by Stephen R. Hooper, Marc B. Lande, Joseph T. Flynn, Coral D. Hanevold, Kevin E. Meyers, Joshua Samuels, Richard C. Becker, Stephen R. Daniels, Bonita E. Falkner, Michael A. Ferguson, et al.

    BACKGROUND: We studied whether increased systolic blood pressure (SBP), as determined by auscultatory SBP, ambulatory SBP, and the number of cardiovascular health risk indicators, are associated with neurocognition in adolescents. METHODS: This cross-sectional study included 365 adolescents (mean age, 15.5 years) from 6 academic medical centers in the United States. The sample was 59.5% male, 52.6% White, with 23.9% of the caregivers having less than or equal to a high school degree. Primary exposures included the following: auscultatory SBP, ambulatory SBP, and the number of cardiovascular risk factors. Neurocognitive outcomes comprised nonverbal IQ, attention, and parent ratings of executive functions. RESULTS: After examining the models for the effects of targeted covariates (eg, maternal education), higher auscultatory SBP was associated with lower nonverbal IQ (β=−1.39; P P P P 2 =0.08–0.09). Higher ambulatory blood pressure sleep SBP also was significantly associated with parent ratings of behavior regulation (β=12.61; P P P <0.01), and all parent ratings of executive functions. CONCLUSIONS: Elevated SBP, even below the hypertension range, and general cardiovascular health are associated with neurocognitive outcomes in adolescents. How these findings might guide clinical care is worthy of additional study.